pca 4230 has been researched along with Thrombosis in 2 studies
*Thrombosis: Formation and development of a thrombus or blood clot in the blood vessel. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cillero, FJ; Fau de Casa-Juana, M; Ortega, MP; Priego, JG; Sunkel, CE | 1 |
Gutiérrez Díaz, JA; Ortega, MP; Priego, JG; Sunkel, C; Tolón, RM | 1 |
2 other study(ies) available for pca 4230 and Thrombosis
Article | Year |
---|---|
Synthesis, platelet aggregation inhibitory activity, and in vivo antithrombotic activity of new 1,4-dihydropyridines.
Topics: Animals; Cats; Collagen; Dihydropyridines; Humans; Kinetics; Male; Mice; Nitrendipine; Platelet Aggregation; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Thrombosis | 1988 |
Interaction of platelets with subendothelium in rats treated with PCA-4230, a new antithrombotic agent. Effect of PCA-4230 on experimental thrombosis.
Topics: Animals; Blood Platelets; Carotid Arteries; Dihydropyridines; Fibrinogen; Fibrinolytic Agents; Male; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Thrombosis; Thromboxane B2; Ticlopidine | 1992 |